Kambiz Yazdi Analyst PerformanceAnalyst at BTIG ResearchKambiz Yazdi is a stock analyst at BTIG Research in the medical sector, covering 7 publicly traded companies. Over the past year, Kambiz Yazdi has issued 27 stock ratings, including strong buy and buy recommendations. While full access to Kambiz Yazdi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kambiz Yazdi's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings29 Last 1 YearsBuy Recommendations100.00% 28 Buy RatingsCompanies Covered7 Unique Companies Ratings Distribution28RatingsDistribution of strong buy, buy, hold, and sell ratings by Kambiz Yazdi.RatingPercentageCount Strong Buy14.3%4 ratings Buy85.7%24 ratings Hold0.0%0 ratings Sell0.0%0 ratingsOut of 28 total stock ratings issued by Kambiz Yazdi at BTIG Research, the majority (85.7%) have been Buy recommendations, followed by 14.3% Strong Buy.Best & Worst CallsBest Call000.0%AVTXMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ARQTMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ7 companiesKambiz Yazdi, an analyst at BTIG Research, currently covers 7 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical7 companies100.0%Kambiz Yazdi of BTIG Research specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE5 companies71.4%MED - DRUGS2 companies28.6% Kambiz Yazdi's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPRAXPraxis Precision Medicines5/20/2026Reiterated Rating$320.61$843.00Buy$0.0000.00% ROISIONSionna Therapeutics5/13/2026Reiterated Rating$40.94$58.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines5/8/2026Reiterated Rating$333.28$843.00Buy$0.0000.00% ROIRAPPRapport Therapeutics5/8/2026Reiterated Rating$39.93$53.00Buy$0.0000.00% ROISIONSionna Therapeutics4/27/2026Reiterated Rating$38.12$58.00Buy$0.0000.00% ROIRAPPRapport Therapeutics4/22/2026Reiterated Rating$36.78$53.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines4/6/2026Reiterated Rating$314.50$843.00Buy$0.0000.00% ROIZVRAZevra Therapeutics3/16/2026Initiated Coverage$9.98$23.00Buy$0.0000.00% ROIVTVTvTv Therapeutics3/11/2026Reiterated Rating$34.33$49.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines3/9/2026Reiterated Rating$312.31Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RAPPRapport Therapeutics3/9/2026Boost Price Target$30.85$47.00Buy$0.0000.00% ROISIONSionna Therapeutics3/2/2026Reiterated Rating$33.73$58.00Buy$0.0000.00% ROIVTVTvTv Therapeutics1/27/2026Reiterated Rating$33.86$49.00Buy$0.0000.00% ROISIONSionna Therapeutics1/14/2026Reiterated Rating$36.81$58.00Buy$0.0000.00% ROISIONSionna Therapeutics1/7/2026Boost Price Target$37.22$58.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/29/2025Reiterated Rating$268.95$843.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/8/2025Set Price Target$247.99$507.00$0.0000.00% ROIRAPPRapport Therapeutics12/8/2025Reiterated Rating$29.50$47.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/5/2025Reiterated Rating$189.97$499.00Buy$0.0000.00% ROIVTVTvTv Therapeutics11/19/2025Initiated Coverage$30.11$40.00Buy$0.0000.00% ROISIONSionna Therapeutics11/19/2025Initiated Coverage$39.12$50.00Buy$0.0000.00% ROIRAPPRapport Therapeutics11/19/2025Initiated Coverage$25.32$47.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines11/18/2025Set Price Target$184.13$424.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines11/18/2025Upgrade$189.32Strong-Buy$0.0000.00% ROIRAPPRapport Therapeutics11/18/2025Upgrade$26.88Strong-Buy$0.0000.00% ROISIONSionna Therapeutics11/18/2025Upgrade$38.41Strong-Buy$0.0000.00% ROIVTVTvTv Therapeutics11/18/2025Upgrade$32.24Strong-Buy$0.0000.00% ROIAVTXAvalo Therapeutics3/25/2025Initiated Coverage$7.63$23.00Buy$00.0000.00% ROIARQTArcutis Biotherapeutics3/11/2025Boost Price Target$15.13$19.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
